Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction
详细信息 查看全文
- 作者：Hai-dong Guo ; Guo-hong Cui ; Jia-jun Yang ; Cun Wang ; Jing Zhu ; Li-sheng Zhang ; Jun Jiang ; Shui-jin Shao
- 关键词：Myocardial infarction ; Angiogenesis ; Transplantation ; Self-assembling peptide ; Cardiac tissue engineering
- 刊名：Biochemical and Biophysical Research Communications
- 出版年：2012
- 出版时间：20 July, 2012
- 年：2012
- 卷：424
- 期：1
- 页码：105-111
- 全文大小：983 K
文摘
Poor vascularization and insufficient oxygen supply are detrimental to the survival of residual cardiomyocytes or transplanted stem cells after myocardial infarction. To prolong and slow the release of angiogenic factors, which stimulate both angiogenesis and vasculogenesis, we constructed a novel self-assembling peptide by attaching the heparin-binding domain sequence LRKKLGKA to the self-assembling peptide RADA16. This designer self-assembling peptide self-assembled into nanofiber scaffolds under physiological conditions, as observed by atomic force microscopy. The injection of designer self-assembling peptides can efficiently provide the sustained delivery of VEGF for at least 1 month. At 4 weeks after transplantation, cardiac function was improved, and scar size and collagen deposition were markedly reduced in the group receiving VEGF with the LRKKLGKA scaffolds compared with groups receiving VEGF alone, LRKKLGKA scaffolds alone or VEGF with RADA16 scaffolds. The microvessel density in the VEGF with LRKKLGKA group was higher than that in the VEGF with RADA16 group. TUNEL and cleaved caspase-3 expression assays showed that the transplantation of VEGF with LRKKLGKA enhanced cell survival in the infarcted heart. These results present the tailor-made peptide scaffolds as a new generation of sustained-release biomimetic biomaterials and suggest that the use of angiogenic factors along with designer self-assembling peptides can lead to myocardial protection, sufficient angiogenesis, and improvement in cardiac function.